Biophytis S.A. (BPTSY)
OTCMKTS · Delayed Price · Currency is USD
0.5000
+0.4890 (4,445.45%)
At close: Jan 21, 2026
Biophytis Employees
Biophytis had 19 employees as of December 31, 2024. The number of employees decreased by 3 or -13.64% compared to the previous year.
Employees
19
Change (1Y)
-3
Growth (1Y)
-13.64%
Revenue / Employee
n/a
Profits / Employee
-$496,338
Market Cap
1.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 19 | -3 | -13.64% |
| Dec 31, 2023 | 22 | -2 | -8.33% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | 4 | 19.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orgenesis | 146 |
| Carisma Therapeutics | 46 |
| International Stem Cell | 32 |
| ZyVersa Therapeutics | 7 |
| Sigyn Therapeutics | 4 |
| Galera Therapeutics | 3 |
Biophytis News
- 10 months ago - Biophytis Targets Mobility Restoration in Patients with Obesity - Newsfile Corp
- 11 months ago - Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity - Newsfile Corp
- 11 months ago - Biophytis Announces New Non-Clinical Data Further Supporting Its Mission to Pioneer the Restoration of Mobility in Patients with Obesity - Newsfile Corp
- 11 months ago - Biophytis Revolutionizes Sarcopenia - Newsfile Corp
- 1 year ago - Biophytis Announces its Participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR) - Newsfile Corp
- 1 year ago - Biophytis Unveils Its Outlook Strategies for 2025 - Newsfile Corp
- 1 year ago - Biophytis Announces Its Participation to the BIOMED FORUM Investor Conference - Newsfile Corp
- 1 year ago - Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China - Newsfile Corp